medRxivGenetic & Genomic MedicinePreprint
Parkinson's disease and multiple system atrophy are gateways to RFC1-related disorders
Violette DelforgeiD, Giulia CoarelliiD, Eugénie MuteziD, Anne‐Sophie RollandiD, Anna WissocqiD, A. Labudeck, C. Marzys, Nazha BOUCETTA, Luc BuéeiD, David L BlumiD, Ana MarquèsiD, Florence DémurgeriD, Jean‐Philippe AzulayiD, Aymeric LanoreiD, PREDISTIM study group, Christelle TessoniD, Suzanne LesageiD, Alexis BriceiD, David GrabliiD, David DevosiD, Alexandra DürriD, Vincent HuiniD
Abstract
Biallelic pathogenic expansions of the RFC1 gene are the genetic cause of cerebellar ataxia, neuropathy, and bilateral vestibular areflexia syndrome. Sensory neuropathy is the most common symptom, but the clinical impairments and gateways to RFC1-related diseases are extremely variable. We genotyped patients with parkinsonism to test the hypothesis that this condition is another such gateway. We screened four cohorts of patients with parkinsonism (n = 2037) for pathogenic expansions in the RFC1 gene. In patients bearing two pathogenic expansions, we excluded the possibility of other pathogenic variants by exome sequencing. We detected 10/2037 (0.5%) biallelic (AAGGG)n RFC1 expansions. The initial diagnosis was Parkinsons disease in five patients, multiple system atrophy in three and atypical parkinsonism in two. Phenotypes perfectly mimicking Parkinsons disease and multiple system atrophy defined according to the international diagnostic criteria may serve as gateways to some RFC1-related disorders. These results could modify the diagnostic and management of these two diseases. The diagnosis and follow-up of patients with parkinsonism should include searches for typical features evocative of a RFC1-relative disease, such as sensory neuropathy or chronic cough. Nerve conduction studies should be conducted in patients with unexplained symptoms of neuropathic pain or sensory neuropathy. We also suggest that RFC1 screening should be performed in patients with atypical parkinsonism or multiple system atrophy with a long survival. Trial Registration Information: The PREDISTIM cohort is registered with ClinicalTrials.gov: NCT02360683 Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=143 SRC="FIGDIR/small/25332961v1_ufig1.gif" ALT="Figure 1"> View larger version (31K): org.highwire.dtl.DTLVardef@89b54borg.highwire.dtl.DTLVardef@dd503aorg.highwire.dtl.DTLVardef@1be1faaorg.highwire.dtl.DTLVardef@110fcd9_HPS_FORMAT_FIGEXP M_FIG C_FIG MSA = multiple system atrophy; PD = Parkinsons disease; RFC1 = replication factor C subunit 1
- organism: human
- assay: whole-exome sequencing
- research focus: differential expression
- approach: statistical model
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Heterozygous and Homozygous RFC1 AAGGG Repeat Expansions are Common in Idiopathic Peripheral Neuropathy
Zitian Tang, Sinem Seleme Övünç, … Sheng Chih Jin·medRxiv·Apr 18, 2025
- Prevalence of RFC1-Mediated Spinocerebellar Ataxia in a United States Ataxia Cohort
Dona Aboud Syriani, Darice Y. Wong, … Brent L. Fogel·Neurology GeneticsPeer-reviewed·May 20, 2020
- Investigation of RFC1 tandem nucleotide repeat locus in diverse neurodegenerative outcomes in an Indian cohort
Nishu Tyagi, Bharathram Uppili, … Mohammed Faruq·medRxiv·Jun 5, 2023
- Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease
Fulya Akçimen, Kensuke Daida, … Kimberley J Billingsley·BrainPeer-reviewed·Nov 29, 2025
- CANVAS causing AAGGG repeat expansions cause tissue-specific reduction in RFC1 expression and increase sensitivity to DNA damage
Riccardo Curró, Natalia Dominik, … Andrea Cortese·bioRxiv·Nov 18, 2025
- Investigation of the pathogenic RFC1 repeat expansion in a Canadian and a Brazilian ataxia cohort: identification of novel conformations
Fulya Akçimen, Jay P. Ross, … Guy Armand Rouleau·Frontiers in GeneticsPeer-reviewed·Nov 22, 2019